TuHURA Biosciences (HURA) Proxy filing summary

Executive summary

• The annual meeting is scheduled for August 18, 2026, via virtual webcast, with stockholders able to vote online or by proxy as of the June 26, 2026 record date.

• Key proposals include director elections, approval of share issuance under a credit facility, executive compensation, auditor ratification, and other business.

• The board unanimously recommends voting in favor of all proposals, including a triennial say-on-pay frequency.

Voting matters and shareholder proposals

• Six incumbent directors are nominated for election to serve until the 2027 annual meeting.

• Approval is sought for issuing 1,878,287 shares to Parkview Holdings One LLC as a loan fee under a $50 million revolving credit facility, requiring shareholder approval under Nasdaq rules.

• Advisory votes are requested on executive compensation and on holding future say-on-pay votes every three years.

• Ratification of Cherry Bekaert LLP as independent auditor for 2026 is proposed.

• Authorization to adjourn the meeting if necessary to solicit additional proxies is included.

Board of directors and corporate governance

• The board consists of six members, with a majority qualifying as independent under Nasdaq rules.

• Committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined charters and independent membership.

• The board separates the roles of Chairman and President, and has adopted a Code of Ethics and an Insider Trading Policy.

• All directors attended at least 75% of meetings in 2025.